Air Products & Chemicals, Inc. (APD) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Air Products & Chemicals, Inc. quarterly Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Air Products & Chemicals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was $637M, a 38.6% increase year-over-year.
  • Air Products & Chemicals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was $2.69B, a 13.6% increase year-over-year.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.69B $637M +$177M +38.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $2.51B $667M +$14.9M +2.29% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-05
Q3 2023 $2.49B $739M +$112M +17.9% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-16
Q3 2023 $2.49B $2.49B +$156M +6.66% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-16
Q2 2023 $2.38B $644M +$16.8M +2.68% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.37B $460M -$102M -18.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $2.47B $652M +$129M +24.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-05
Q3 2022 $2.34B $627M +$9.8M +1.59% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-16
Q3 2022 $2.34B $2.34B +$57.4M +2.52% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-16
Q2 2022 $2.33B $627M +$50.3M +8.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.28B $562M +$13.4M +2.44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.27B $523M -$16.1M -2.99% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-02
Q3 2021 $2.28B $617M +$56.5M +10.1% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-16
Q3 2021 $2.28B $2.28B +$43.8M +1.96% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-16
Q2 2021 $2.22B $577M +$37.9M +7.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.19B $549M -$28.7M -4.97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.22B $539M -$21.9M -3.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 $2.24B $560M -$43M -7.13% Jul 1, 2020 Sep 30, 2020 10-K 2020-11-19
Q3 2020 $2.24B $2.24B +$93.2M +4.35% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-22
Q2 2020 $2.28B $539M -$30.5M -5.35% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.31B $577M +$60.7M +11.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.25B $561M +$106M +23.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $2.14B $603M +$69.5M +13% Jul 1, 2019 Sep 30, 2019 10-K 2020-11-19
Q3 2019 $2.14B $2.14B +$179M +9.1% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-18
Q2 2019 $2.07B $570M +$53.9M +10.5% Apr 1, 2019 Jun 30, 2019 10-K 2020-11-19
Q1 2019 $2.02B $517M +$61.1M +13.4% Jan 1, 2019 Mar 31, 2019 10-K 2020-11-19
Q4 2018 $1.96B $455M -$5.7M -1.24% Oct 1, 2018 Dec 31, 2018 10-K 2020-11-19
Q3 2018 $1.97B $534M +$76.3M +16.7% Jul 1, 2018 Sep 30, 2018 10-K 2019-11-26
Q3 2018 $1.97B $1.97B +$526M +36.5% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-19
Q2 2018 $1.89B $516M +$257M +99.4% Apr 1, 2018 Jun 30, 2018 10-K 2019-11-26
Q1 2018 $1.63B $455M +$59.8M +15.1% Jan 1, 2018 Mar 31, 2018 10-K 2019-11-26
Q4 2017 $1.57B $461M +$132M +40.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-11-26
Q3 2017 $1.44B $457M +$66.4M +17% Jul 1, 2017 Sep 30, 2017 10-K 2018-11-20
Q3 2017 $1.44B $1.44B -$95.1M -6.2% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-26
Q2 2017 $1.37B $259M -$136M -34.4% Apr 1, 2017 Jun 30, 2017 10-K 2018-11-20
Q1 2017 $1.51B $396M +$24M +6.46% Jan 1, 2017 Mar 31, 2017 10-K 2018-11-20
Q4 2016 $1.49B $328M -$44.2M -11.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-11-20
Q3 2016 $1.53B $391M +$23.6M +6.42% Jul 1, 2016 Sep 30, 2016 10-K 2017-11-16
Q3 2016 $1.54B $1.54B +$302M +24.5% Oct 1, 2015 Sep 30, 2016 10-K 2018-11-20
Q2 2016 $1.51B $395M +$100M +34% Apr 1, 2016 Jun 30, 2016 10-K 2017-11-16
Q1 2016 $1.41B $372M +$124M +50.1% Jan 1, 2016 Mar 31, 2016 10-K 2017-11-16
Q4 2015 $1.28B $373M +$48.7M +15% Oct 1, 2015 Dec 31, 2015 10-K 2017-11-16
Q3 2015 $1.23B $367M +$223M +155% Jul 1, 2015 Sep 30, 2015 8-K 2017-06-05
Q3 2015 $1.23B $1.23B +$309M +33.4% Oct 1, 2014 Sep 30, 2015 10-K 2017-11-16
Q2 2015 $1.01B $295M -$119M -28.8% Apr 1, 2015 Jun 30, 2015 8-K 2017-06-05
Q1 2015 $1.13B $248M -$137M -35.7% Jan 1, 2015 Mar 31, 2015 8-K 2017-06-05
Q4 2014 $1.27B $324M -$61.8M -16% Oct 1, 2014 Dec 31, 2014 8-K 2017-06-05
Q3 2014 $1.33B $144M -$35.1M -19.6% Jul 1, 2014 Sep 30, 2014 10-K 2015-11-24
Q3 2014 $924M $924M -$400M -30.2% Oct 1, 2013 Sep 30, 2014 8-K 2017-06-05
Q2 2014 $1.36B $414M +$30.7M +8.01% Apr 1, 2014 Jun 30, 2014 10-K 2015-11-24
Q1 2014 $1.33B $385M -$5M -1.28% Jan 1, 2014 Mar 31, 2014 10-K 2015-11-24
Q4 2013 $1.34B $386M +$13.2M +3.55% Oct 1, 2013 Dec 31, 2013 10-K 2015-11-24
Q3 2013 $1.32B $179M +$21.3M +13.5% Jul 1, 2013 Sep 30, 2013 10-K 2014-11-24
Q3 2013 $1.32B $1.32B +$42M +3.28% Oct 1, 2012 Sep 30, 2013 10-K 2015-11-24
Q2 2013 $1.3B $383M -$99.7M -20.7% Apr 1, 2013 Jun 30, 2013 10-K 2014-11-24
Q1 2013 $1.4B $390M +$102M +35.4% Jan 1, 2013 Mar 31, 2013 10-K 2014-11-24
Q4 2012 $1.3B $372M +$18.6M +5.26% Oct 1, 2012 Dec 31, 2012 10-K 2014-11-24
Q3 2012 $1.28B $158M -$238M -60.1% Jul 1, 2012 Sep 30, 2012 10-K 2013-11-26
Q3 2012 $1.28B $1.28B -$226M -15% Oct 1, 2011 Sep 30, 2012 10-K 2014-11-24
Q2 2012 $1.52B $483M +$95.1M +24.5% Apr 1, 2012 Jun 30, 2012 10-K 2013-11-26
Q1 2012 $1.42B $288M -$106M -26.9% Jan 1, 2012 Mar 31, 2012 10-K 2013-11-26
Q4 2011 $1.53B $354M +$22.6M +6.82% Oct 1, 2011 Dec 31, 2011 10-K 2013-11-26
Q3 2011 $1.51B $395M +$28.4M +7.74% Jul 1, 2011 Sep 30, 2011 10-K 2012-11-20
Q3 2011 $1.51B $1.51B +$240M +19% Oct 1, 2010 Sep 30, 2011 10-K 2013-11-26
Q2 2011 $1.48B $388M +$51.3M +15.3% Apr 1, 2011 Jun 30, 2011 10-K 2012-11-20
Q1 2011 $1.43B $394M +$53.2M +15.6% Jan 1, 2011 Mar 31, 2011 10-K 2012-11-20
Q4 2010 $1.38B $331M Oct 1, 2010 Dec 31, 2010 10-K 2012-11-20
Q3 2010 $367M Jul 1, 2010 Sep 30, 2010 10-K 2011-11-22
Q3 2010 $1.27B $1.27B Oct 1, 2009 Sep 30, 2010 10-K 2012-11-20
Q2 2010 $336M Apr 1, 2010 Jun 30, 2010 10-K 2011-11-22
Q1 2010 $341M Jan 1, 2010 Mar 31, 2010 10-K 2011-11-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.